Medical/Pharmaceuticals
Once-Weekly TransCon™ CNP Achieved Primary Efficacy Objective in ACcomplisH China Phase 2 Trial
SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- VISEN Pharmaceuticals (VISEN), an innovative biopharmaceutical company focused on endocrine diseases, is pleased to announce the topline results from the ACcomplisH China Phase 2 Trial in children with achondroplasia (ACH) aged 2 to 10 years. In the trial, ...
2023-11-16 22:00
1561
Heuron to Participate in RSNA 2023, Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke
SEOUL, South Korea, Nov. 16, 2023 /PRNewswire/ -- Heuron, a medical AI (artificial intelligence) imaging software solution company, under the leadership of CEO Dr.Donghoon Shin, is scheduled to take part in the 2023 Radiological Society ofNorth America (RSNA) conference, scheduled for this month...
2023-11-16 21:00
1629
TB Alliance Launches Five-Country Phase 2 Clinical Trial Evaluating Next-Generation TB Drug
Early results presented at the Union World Conference on Lung Health suggest promise of new compound to fight tuberculosis that will be tested as part of Phase 2 trial The first participant has been dosed in this partially double-blind study to evaluate the safety and efficacy of what has the po...
2023-11-16 20:20
1422
ACROBiosystems launches GMP-grade DLL4 Protein to accelerate stem cell manufacturing
NEWARK, Del., Nov. 16, 2023 /PRNewswire/ -- ACROBiosystems, a global cornerstone of the pharmaceutical industry committed to offering innovative tools and solutions, recently announces the launch of GMP grade DLL4. GMP grade DLL4 is a recombinant, soluble form of Delta-like Ligand 4, or DLL4, ...
2023-11-16 20:08
1430
CU Medicine develops novel microbiome technology MOZAICTM for faecal microbiota transplantation
Enhancing treatment success for Clostridioides difficile infections to over 90% HONG KONG, Nov. 16, 2023 /PRNewswire/ -- Clostridioides difficile infection (CDI) is a common hospital-acquired infection worldwide. Recurrence and mortality rates have been reported to be up to 35% and 40%, respectiv...
2023-11-16 17:26
1906
AXA Study: Hong Kong silver-haired enjoy better mind health, yet are concerned about financial and health challenges
HONG KONG, Nov. 16, 2023 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today released the fourth-phase findings of its annual AXA Study of Mind Health and Wellbeing 2023 (the Study) which assessed the state of mind health[1] across the globe. The Study reveals that the silver-haired generation in...
2023-11-16 15:03
2077
Apollo Hospitals Celebrates 25 Years of India's First Liver Transplant Program
* Apollo Hospitals pioneered India's first successful liver transplant in 1998. * The first liver transplant patient, who was 20 months old at the time, is now a doctor. * Apollo Hospitals has played a leading role in positioning India as a global leader in organ transplantation NEW DELHI, ...
2023-11-16 14:41
2164
Jiahui Health develops international CAR-T treatment platform in China
SHANGHAI, Nov. 16, 2023 /PRNewswire/ -- On 10 November 2023, the sixth China International Import Expo (CIIE) successfully concluded at the National Exhibition and Convention Center inShanghai. This year, Jiahui provided healthcare support for the China International Import Expo (CIIE) as the de...
2023-11-16 12:15
2074
1 in 25 carries a genotype that is associated with a shortened lifespan
Scientists at deCODE genetics, a subsidiary of Amgen, have published a study on actionable genotypes detected in the Icelandic population and their association with lifespan. The results of this study are among the things that have motivated the government ofIceland to announce a nation wide effo...
2023-11-16 00:02
737
Lunit Secures $150 Million in Capital Increase
* Fund fully paid-in as of November 9, achieving over 100% shareholder participation SEOUL, South Korea, Nov. 15, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the successful completion of a signi...
2023-11-15 22:00
1910
The PolG Foundation awards over $3.5M in academic grants to pioneer POLG research
NEW YORK and PARIS, Nov. 15, 2023 /PRNewswire/ --The PolG Foundation is a nascent foundation established in 2022 by a PolG family, with the mission to support and accelerate research to find effective treatments and a cure for PolG mitochondrial disorders. To view the Multimedia News Release, p...
2023-11-15 20:42
1877
Henlius Reported Financial Results for the First Three Quarters of 2023: Total Revenue Exceeded RMB3.9 billion, Profitability Further Improved
SHANGHAI, Nov. 15, 2023 /PRNewswire/ -- Henlius（2696.HK）announced its financial results and business update for the first three quarters of 2023. As of September 30, 2023, Henlius generated a total revenue of RMB3.9278 billion, rising by 84.0% YoY, and a profit totaledRMB407.8 million, attributed ...
2023-11-15 20:16
2907
RemeGen to Present Telitacicept Phase III Clinical Trial Results for Rheumatoid Arthritis Patients in a Late-Breaking Abstract Oral Presentation Session at the American College of Rheumatology
YANTAI, China, Nov. 15, 2023 /PRNewswire/ -- RemeGen Co., Ltd.
2023-11-15 16:35
1833
BMC Celebrates World COPD Day 2023 With Innovative Products and Global Events
BEIJING, Nov. 15, 2023 /PRNewswire/ -- World COPD Day is a global campaign that aims to raise awareness of chronic obstructive pulmonary disease (COPD) and improve the quality of life for people living with this condition1. COPD is a group of progressive lung diseases that cause breathing difficu...
2023-11-15 15:40
1275
CCHIO, a Milestone Event for the Global Cancer Community, Returns to Tianjin in 2023
Bringing together expertise to pool wisdom in China and around the world. TIANJIN, China, Nov. 15, 2023 /PRNewswire/ -- The 2023 edition of the Chinese Congress of Holistic Integrative Oncology will be held fromNovember 16th to 19th in Tianjin,China. Organized by the China Anti-Cancer Association...
2023-11-15 15:10
1137
"Read Medicine Labels" - How to Safely Use Green Chiretta Against COVID-19
Chula
2023-11-15 14:58
2772
Riding the tide, realize the future: The BD paths for Chinese Biotech
WUXI, China, Nov. 14, 2023 /PRNewswire/ -- 2023 BIO-Europe just closed last week. In line with previous conferences, this BD carnival attracted more than 2,000 companies, 5,000 attendees from close to 60 countries all over the world. Recently, we interviewed a global BD expert, Dr. Kaan Certel. ...
2023-11-15 10:42
1278
BioDuro-Sundia Radioisotope Laboratory Technology Upgrades Accelerate Innovation
SHANGHAI, Nov. 15, 2023 /PRNewswire/ -- Radioisotope assays a microanalytical method that uses radionuclides as tracers to label research objects. Compared with conventional biological sample detection techniques, Radioisotope assay has distinct advantages such as high specificity, high sensitivi...
2023-11-15 09:00
1758
EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023
DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc.
2023-11-14 22:31
1733
Lunit Nets FDA Nod for AI-Powered 3D Breast Tomosynthesis Solution, Lunit INSIGHT DBT
- Lunit INSIGHT DBT receives FDA 510(k) clearance, poised to enter the world's largest DBT market SEOUL, South Korea, Nov. 14, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced that it has received U.S....
2023-11-14 22:00
1798
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
9273
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7751